[1] ROACH M C, ROBINSON C G, DEWEES T A, et al. Stereotactic body radiation therapy for central early-stage NSCLC:results of a prospective phase Ⅰ/Ⅱ trial[J]. J Thorac Oncol, 2018, 13(11):1727-1732. [2] ISLAMI F, FERLAY J, LORTET-TIEULENT J, et al. International trends in anal cancer incidence rates[J]. Int J Epidemiol, 2017, 46(3):924-938. [3] POSTMUS P E, KERR K M, OUDKERK M, et al. Early and locally advanced non-small-cell lung cancer (NSCLC):ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up[J]. Anna Oncol, 2017, 28(4):1-21. [4] SARVI S, MACKINNON A C, AVLONITIS N, et al. CD133+ cancer stem-like cells in small cell lung cancer are highly tumorigenic and chemoresistant but sensitive to a novel neuropeptide antagonist[J]. Cancer Res, 2014, 74(5):1554-1565. [5] SANTANA-DAVILA R, CHOW L Q. The use of combination immunotherapies as front-line therapy for non-small-cell lung cancer[J]. Future Oncol, 2018, 14(3):191-194. [6] WATANABE M, KAWAGUCHI T, ISA S, et al. Ultra-sensitive detection of the pretreatment EGFR T790M mutation in non-small cell lung cancer patients with an EGFR-activating mutation using droplet digital PCR[J]. Clin Cancer Res, 2015, 21(15):3552-3560. [7] CHRISTENSEN N L, JEKUNEN A, HEINONEN S, et al. Lung cancer guidelines in Sweden, Denmark, Norway and Finland:a comparison[J]. Acta Oncol, 2017, 56(7):943-948. [8] SORIA J, WU Y L, NAKAGAWA K, et al. Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS):a phase 3 randomised trial[J]. Lancet Oncol, 2015, 16(8):990-998. [9] GUO M Z, LI X S, XU H R, et al. Rhein inhibits liver fibrosis induced by carbon tetrachloride in rats[J]. Acta Pharmacol Sin, 2002, 23(8):739-744. [10] NAMVARAN A, FAZELI M, FARAJNIA S, et al. Apoptosis and caspase 3 pathway role on anti-proliferative effects of scrophulariaoxy sepala methanolic extract on Caco-2 cells[J]. Drug Res(Stuttg), 2017, 67(9):547-552. [11] GAO Y, CHEN X, FANG L, et al. Rhein exerts pro- and anti-inflammatory actions by targeting IKKβ inhibition in LPS-activated macrophages[J]. Free Radic Biol Med, 2014, 72:104-112. [12] HU G Y, PENG C, XIE X F, et al. Availability, pharmaceutics, security, pharmacokinetics, and pharmacological activities of patchouli alcohol[J].Evid Based Complement Alternat Med,2017,2017:4850612. [13] ZHOU G G, PENG F H, ZHONG Y P, et al. Rhein suppresses matrix metalloproteinase production by regulating the Rac1/ROS/MAPK/AP-1 pathway in human ovarian carcinoma cells[J]. Int J Oncol, 2017, 50(3):933-941. [14] LIU S, WANG J, SHAO T, et al. The natural agent rhein induces β-catenin degradation and tumour growth arrest[J]. J Cell Mol Med, 2018, 22(1):589-599. [15] 钱文斌. 大黄酸对乳腺癌肿瘤细胞HER-2蛋白表达的影响研究[J]. 中华中医药学刊, 2015, 33(1):224-226. [16] CHO J H, CHAE J I, SHIM J H. Rhein exhibits antitumorigenic effects by interfering with the interaction between prolyl isomerase Pin1 and c-Jun[J]. Oncol Rep, 2017, 37(3):1865-1872. [17] SHI Y K, AU J S, THONGPRASERT S, et al. A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology(PIONEER)[J]. J Thorac Oncol, 2014, 9(2):154-162. [18] WANG L L, MA G Y, ZHANG Y B, et al. Effect of mitochondrial cytochrome c release and its redox state on the mitochondrial-dependent apoptotic cascade reaction and tenderization of yak meat during postmortem aging[J]. Food Res Int, 2018, 111:488-497. [19] VANDE VELDE C, CIZEAU J, DUBIK D,et al. BNIP3 and genetic control of necrosis-like cell death through the mitochondrial permeability transition pore[J]. Mol Cell Biol, 2000, 20(15):5454-5468. [20] LIU X, KIM C N, YANG J, et al. Induction of apoptotic program in cell free extracts:requirement for dATP and cytochrome C[J]. Cell, 1996, 86(1):147-157. [21] SINGH M H, BROOKE S M, ZEMLYAK I, et al. Evidence for caspase effects on release of cytochrome c and AIF in a model of ischemia in cortical neurons[J]. Neurosci Lett, 2010, 469(2):179-183. [22] YU X C, WANG L, ACEHAN D, et al. Three-dimensional structure of a double apoptosome formed by the Drosophila Apaf-1 related killer[J]. J Mol Biol, 2006, 355(3):577-589. [23] MISEVICIENE L, ANUSEVICIUS Z, SARLAUSKAS J, et al. Redox reactions of the FAD-containing apoptosis-inducing factor (AIF) with quinoidal xenobiotics:a mechanistic study[J]. Arch Biochem Biophys, 2011, 512(2):183-189. [24] SCOVASSI A I, SOLDANI C, VENERONI P, et al. Changes of mitochondria and relocation of the apoptosis-inducing factor during apoptosis[J]. Ann N Y Acad Sci, 2009, 117(1):12-17. [25] BENÍTEZ-GUZMÁN A, ARRIAGA-PIZANO L,MORÁN J, et al. Endonuclease G takes part in AIF-mediated caspase-independent apoptosis in Mycobacterium bovis-infected bovine macrophages[J]. Vet Res, 2018, 49(1):69-72. [26] CHIPUK J E,KUWANA T,BOUCHIERHAYES L, et al. Direct activation of bax by p53 mediates mitoc; hondrial membrane permeabilization and apoptosis[J]. Science, 2004, 303(5660):1010-1014. [27] RAASCHOU NIELSEN O, ANDERSEN Z J, BEELEN R, et al. Air pollution and lung cancer incidence in 17 European cohorts:prospective analyses from the European Study of Cohorts for Air Pollution Effects(ESCAPE)[J]. Lancet Oncol, 2013, 14(9):813-822. [28] PAN Q, PAN H M, LOU H Z, et al. Inhibition of the angiogenesis and growth of Aloin in human colorectal cancer in vitro and in vivo[J]. Cancer Cell Int, 2013, 13(1):69. [29] ZHOU Y X, XIA W, YUE W, et al. Rhein:a review of pharmacological activities[J]. Evid Based Complement Alternat Med, 2015, 2015:578107. [30] CHEN Y Y, CHIANG S Y, LIN J G, et al. Emodin, aloe-emodin and rhein inhibit migration and invasion in human tongue cancer SCC-4 cells through the inhibition of gene expression of matrix metalloproteinase-9[J]. Int J Oncol, 2010, 36(5):1113-1120. |